Study Experience

CIS has conducted Phase I through Phase IV Studies. These studies have focused on pharmacokinetic, bioequivalence, and drug interactions in healthy, normal, and targeted patient populations. The following list demonstrates a historical version of several of the studies conducted.

Our recent and primary therapeutic areas of study include:

Cardiology	Obstetrics & Gynecology
Endocrinology	Pain Management
Family Medicine	Psychiatry
Internal Medicine	Rheumatology
Neurology	Dermatology
Obesity & Weight Management	Women's Health

Completed Studies Include:

Indication	Therapeutic Area	Conducted	Phase
Diabetes Mellitus	Endocrine Metabolism	93	Phase I, II, III
Hypertension	Cardiovascular/Renal	20	Phase I, II, III, IV
Osteoarthritis	Autoimmune Disease	19	Phases II, III
Gout	Musculoskeletal Pain/Inflammation	18	Phase II, III
Chronic Lower Back Pain	Neurology	17	Phase III
Low Back Pain	Pain	17	Phase II, III
Fibromyalgia	Pain Management	15	Phase II, III
Obesity	Cardiology	14	Phase II, III
Migraine	Neurology	13	Phase III
Asthma	Allergy/ Asthma Pediatrics/ Adults	10	Phase I, II, III
Hyperlipidemia	Cardiology	9	Phase II, III
Dyslipidemia	Cardio-Endocrine Metabolism	8	Phase III
Cardiovascular Events	Cardiology	7	Phase III
Hypercholesterolemia	Cardiology	7	Phase II, III
Overactive Bladder	Urology	7	Phase III
Influenza	Infectious Diseases	6	Phase I, II, III
Rheumatoid Arthritis	Rheumatology	6	Phase II
Atrial Fibrillation	Cardiology	5	Phase II, III
Breast Cancer	Oncology	5	Phase I, II, III
Cancer	Oncology	5	Phase I, II
Chronic Headache	CNS	5	Phase II, III
Hypogonadism	Urology	5	Phase I, III
Narcotic Analgesic/ Pain	Oncology	5	Phase I
Angina	Cardio Renal	4	Phase III
Anticoagulants	Hematology	4	Phase II
Cardiology	Cardio Renal	4	Phase I
Chronic Non-Cancer Pain	Pain Management	4	Phase II, III
Analgesic	Child Pediatrics	3	Phase III
COPD	Pulmonary	3	Phase I
Endometriosis	Women’s Health	3	Phase III
Glaucoma / Vitreous Hemorrhage	Ophthalmology	3	Phase II
Infant Formula	Pediatrics	3	Phase III
Sinusitis	Otolaryngology	3	Phase I
Sunscreen	Dermatology / Pediatrics	3	Phase III, IV
Dementia	CNS	2	Phase II
Acute Bacterial Bronchitis	Pulmonary	2	Phase I
Acute Coronary Syndrome	Cardiology	2	Phase III
Adolescents Headache	Neurology	2	Phase IV
Allergic Rhinitis	Allergy and Asthma	2	Phase I
Alzheimer Dementia	Neurology	2	Phase III
Antiemetic	Pediatrics	2	Phase III
Antipyretic	Analgesic Pediatrics	2	Phase III
Antipyretic	Analgesic Pediatrics	2	Phase I
Antipyretic	Child Pediatrics	2	Phase III
Antipyretic - extended release	Analgesic Pediatrics	2	Phase II
Antiviral Immunogenicity Vaccine	Pediatrics	2	Phase III
Bipolar Disorder	Psychiatry	2	Phase I
Depression	Psychiatry	2	Phase I
Diabetic Heart Disease	CVOT	2	Phase II, III
DVT Prevention in Ortho Surgery	Orthopedic	2	Phase II, III
Erectile Dysfunction	Urology	2	Phase II, III
Gastroenteritis	Gastroenterology	2	Phases II
Herpes/Genitalis	Infectious Diseases	2	Phase II
HIV	Infectious Diseases	2	Phase III
Hormone Replacement Therapy	Women’s Health	2	Phase I
Myocardial Ischemia / MI	Cardio Renal	2	Phase III
Peripheral Arterial Disease	Cardiology	2	Phase II
Post Herpetic Neurology	Neurology	2	Phase III
Pulmonary Hypertension	Cardiology	2	Phase II
Renal Impairment	Nephrology	2	Phase I
Bacterial Conjunctivitis	Ophthalmology	1	Phase II
Bacterial Infections	Anti-infective	1	Phase II
Birth Control	Women’s Health	1	Phase I
BPH	Urology	1	Phase I
Colo-Rectal Cancer Screening	Gastroenterology	1	Diagnostic
Cough & Cold allergies	Allergy and Asthma	1	Phase I
Epilepsy	Neurology	1	Phases I,II,III,IV
Hemorrhoids	Gastroenterology	1	Phase III
Inflammation	Infectious Diseases	1	Phase I
Measles Vaccine	Pediatric Immunogenicity	1	Phase III
Opioid Induced Constipation	Gastroenterology	1	Phase III
Premenstrual Dysphoric Disorder	Women's Health	1	Phase II
Psoriasis	Dermatology	1	Phase II
Seizures	Neurology	1	Phases I,II,III,IV
Stroke	Neurology	1	Phase III
Tonsillectomy	Otolaryngology	1	Phase I
Trauma/Head Injury	Neurosurgery	1	Phase I
Urinary Tract Infections	Urology	1	Phase II
Vaccinations (infants)	Pediatric Immunogenicity	1	Phase III

Hospitals and emergency rooms are located close to our clinics.

We encourage you to learn more about how CIS can help you enroll your clinical study quickly. Please contact Susan Corder, Business Development Coordinator, at:

Phone: 847-599-2492 x103

Email: scorder@cisresearch.com